Literature DB >> 22576799

The microRNA expression associated with morphogenesis of breast cancer cells in three-dimensional organotypic culture.

Hong T Nguyen1, Cui Li2, Zhen Lin3, Yan Zhuang1, Erik K Flemington3, Matthew E Burow1, Y I Lin4, Bin Shan1.   

Abstract

Three-dimensional organotypic culture using reconstituted basement membrane matrix Matrigel (rBM 3-D) is an indispensable tool to characterize morphogenesis of mammary epithelial cells and to elucidate the tumor-modulating actions of extracellular matrix (ECM). microRNAs (miRNAs) are a novel class of oncogenes and tumor suppressors. The majority of our current knowledge of miRNA expression and function in cancer cells is derived from monolayer 2-D culture on plastic substratum, which lacks consideration of the influence of ECM-mediated morphogenesis on miRNAs. In the present study, we compared the expression of miRNAs in rBM 3-D and 2-D cultures of the non-invasive MCF-7 and the invasive MDA-MB231 cells. Our findings revealed a profound difference in miRNA profiles between 2-D and rBM 3-D cultures within each cell type. Moreover, rBM 3-D culture exhibited greater discrimination in miRNA profiles between MCF-7 and MDA-MB231 cells than 2-D culture. The disparate miRNA profiles correlated with distinct mass morphogenesis of MCF-7 and invasive stellate morphogenesis of MDA-MB231 cells in rBM 3-D culture. Supplementation of the tumor promoting type I collagen in rBM 3-D culture substantially altered the miRNA signature of mass morphologenesis of MCF-7 cells in rBM 3-D culture. Overexpression of the differentially expressed miR-200 family member miR429 in MDA-MB231 cells attenuated their invasive stellate morphogenesis in rBM 3-D culture. In summary, we provide the first miRNA signatures of morphogenesis of human breast cancer cells in rBM 3-D culture and warrant further utilization of rBM 3-D culture in investigation of miRNAs in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576799      PMCID: PMC3991116          DOI: 10.3892/or.2012.1764

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  28 in total

1.  Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429.

Authors:  Zhen Lin; Xia Wang; Claire Fewell; Jennifer Cameron; Qinyan Yin; Erik K Flemington
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

2.  geWorkbench: an open source platform for integrative genomics.

Authors:  Aris Floratos; Kenneth Smith; Zhou Ji; John Watkinson; Andrea Califano
Journal:  Bioinformatics       Date:  2010-05-28       Impact factor: 6.937

3.  The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.

Authors:  Paraic A Kenny; Genee Y Lee; Connie A Myers; Richard M Neve; Jeremy R Semeiks; Paul T Spellman; Katrin Lorenz; Eva H Lee; Mary Helen Barcellos-Hoff; Ole W Petersen; Joe W Gray; Mina J Bissell
Journal:  Mol Oncol       Date:  2007-06       Impact factor: 6.603

4.  MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.

Authors:  X Rao; G Di Leva; M Li; F Fang; C Devlin; C Hartman-Frey; M E Burow; M Ivan; C M Croce; K P Nephew
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

Review 5.  MicroRNAs as potential cancer therapeutics.

Authors:  P Trang; J B Weidhaas; F J Slack
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

6.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 7.  Small is beautiful: microRNAs and breast cancer-where are we now?

Authors:  E T Verghese; A M Hanby; V Speirs; T A Hughes
Journal:  J Pathol       Date:  2008-07       Impact factor: 7.996

Review 8.  Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression.

Authors:  Marcus E Peter
Journal:  Cell Cycle       Date:  2009-03-22       Impact factor: 4.534

9.  Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition.

Authors:  Bin Shan; Tso-pang Yao; Hong T Nguyen; Ying Zhuo; Dawn R Levy; Ross C Klingsberg; Hui Tao; Michael L Palmer; Kevin N Holder; Joseph A Lasky
Journal:  J Biol Chem       Date:  2008-05-21       Impact factor: 5.157

10.  Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.

Authors:  Katherine J Martin; Denis R Patrick; Mina J Bissell; Marcia V Fournier
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

View more
  12 in total

1.  Three-Dimensional Organotypic Cultures Reshape the microRNAs Transcriptional Program in Breast Cancer Cells.

Authors:  Yarely M Salinas-Vera; Jesús Valdés; Alfredo Hidalgo-Miranda; Mireya Cisneros-Villanueva; Laurence A Marchat; Stephanie I Nuñez-Olvera; Rosalio Ramos-Payán; Carlos Pérez-Plasencia; Lourdes A Arriaga-Pizano; Jessica L Prieto-Chávez; César López-Camarillo
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

2.  Comparative profiling of miRNA expression of lung adenocarcinoma cells in two-dimensional and three-dimensional cultures.

Authors:  Cui Li; Hong T Nguyen; Yan Zhuang; Zhen Lin; Erik K Flemington; Ying Zhuo; Stephen P Kantrow; Gilbert F Morris; Deborah E Sullivan; Bin Shan
Journal:  Gene       Date:  2012-10-02       Impact factor: 3.688

Review 3.  Illustrating the interplay between the extracellular matrix and microRNAs.

Authors:  Anna M Piccinini; Kim S Midwood
Journal:  Int J Exp Pathol       Date:  2014-04-25       Impact factor: 1.925

Review 4.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.

Authors:  Gloria Bertoli; Claudia Cava; Isabella Castiglioni
Journal:  Theranostics       Date:  2015-07-13       Impact factor: 11.556

5.  Gene and miRNA expression signature of Lewis lung carcinoma LLC1 cells in extracellular matrix enriched microenvironment.

Authors:  Vaidotas Stankevicius; Gintautas Vasauskas; Danute Bulotiene; Stase Butkyte; Sonata Jarmalaite; Ricardas Rotomskis; Kestutis Suziedelis
Journal:  BMC Cancer       Date:  2016-10-11       Impact factor: 4.430

6.  How interacting pathways are regulated by miRNAs in breast cancer subtypes.

Authors:  Claudia Cava; Antonio Colaprico; Gloria Bertoli; Gianluca Bontempi; Giancarlo Mauri; Isabella Castiglioni
Journal:  BMC Bioinformatics       Date:  2016-11-08       Impact factor: 3.169

7.  Induction of a novel isoform of the lncRNA HOTAIR in Claudin-low breast cancer cells attached to extracellular matrix.

Authors:  Miao Li; Xi Li; Yan Zhuang; Erik K Flemington; Zhen Lin; Bin Shan
Journal:  Mol Oncol       Date:  2017-10-30       Impact factor: 6.603

8.  Src-mediated morphology transition of lung cancer cells in three-dimensional organotypic culture.

Authors:  Hong T Nguyen; Yan Zhuang; Lichun Sun; Steven P Kantrow; Jay K Kolls; Zongbing You; Ying Zhuo; Bin Shan
Journal:  Cancer Cell Int       Date:  2013-02-14       Impact factor: 5.722

9.  Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen.

Authors:  Yan Zhuang; Xiang Wang; Hong T Nguyen; Ying Zhuo; Xinpeng Cui; Claire Fewell; Erik K Flemington; Bin Shan
Journal:  J Hematol Oncol       Date:  2013-05-13       Impact factor: 17.388

Review 10.  Functions of lncRNA HOTAIR in lung cancer.

Authors:  Gregory Loewen; Janarthanan Jayawickramarajah; Ying Zhuo; Bin Shan
Journal:  J Hematol Oncol       Date:  2014-12-10       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.